Cognitive Functions on Coronary Surgery
The Effect of Intraoperative Arterial Oxygen Levels on Cognitive Functions After Coronary Bypass Graft Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to examine the effects of different but safe levels of arterial oxygen levels used in cardiac surgeries on cerebral oxygenation during the operation. It is also to investigate the effect on cognitive functions in the postoperative period. For our study the investigators will conduct a randomized control trial. Patients will be randomly assigned to one of two possible study groups according to the arterial oxygen levels.If there is any abnormality in cerebral oxygen levels during surgery, necessary intervention will be made by doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 20, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2021
CompletedMarch 29, 2023
March 1, 2023
6 months
January 20, 2021
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
postoperative neurocognitive function
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
12 hours after surgery
postoperative neurocognitive function
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
24 hours after surgery
postoperative neurocognitive function
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
1 month after surgery
postoperative neurocognitive function
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
3 months after surgery
postoperative neurocognitive function
Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.
6 months after surgery
Secondary Outcomes (1)
Extubation time after surgery
During the hospitalization for postoperative recovery ,average 8 days
Study Arms (2)
normoxy
EXPERIMENTALGroup 1(n=50) FiO2%40, PaO2\<180 ve PaO2≥80mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored. An rSO2 less than 45% triggered an alarm, the anesthesiologist timed the event, and after 60 seconds initiated an intervention protocol means; PaO2 levels were checked, PaO2\> 100 mmHg was achieved, if not improved, pump blood flow, mean arterial pressure were increased, if there is still no response and hematocrit \<20%, patients were scheduled for erythrocyte transfusion until the rSO2 was restored to at least 60% at both probes.In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.
hyperoxia
EXPERIMENTALGroup 2(n=50) FiO2%100, PaO2≥180mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored..In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.
Interventions
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
Eligibility Criteria
You may qualify if:
- adult patients scheduled to undergo elective cardiopulmonary bypass graft surgery
You may not qualify if:
- severe preoperative cognitive impairment(i.e. dementia, intellectual disorder)
- Non-Turkish speaking patients
- presence of end-stage organ failure
- patients requiring emergency coronary surgery
- surgical procedures requiring single lung ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa YIERH
Bursa, 16200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuğba T ONUR, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Ümran Ü KARACA, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Filiz F ATA, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Halil Erkan H SAYAN, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Anıl A ONUR, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Canan C YILMAZ, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Ayşe Neslihan AN BALKAYA, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Cüneyt C ERİŞ
Bursa Yuksek Ihtisas Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 20, 2021
First Posted
January 27, 2021
Study Start
November 1, 2019
Primary Completion
May 1, 2020
Study Completion
August 1, 2020
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share